Drug
HL151
HL151 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
50%
Ph phase_3
2
50%
Phase Distribution
2
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 3Large-scale testing
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (50.0%)
Phase 32 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
NCT03655210
completedphase_3
Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus
NCT03317301
completedphase_1
Single Dosing Clinical Trial of HL151
NCT02682745
completedphase_1
Repeated Dosing Clinical Trial of HL151
NCT02686294
Clinical Trials (4)
Showing 4 of 4 trials
NCT03655210Phase 3
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
NCT03317301Phase 3
Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus
NCT02682745Phase 1
Single Dosing Clinical Trial of HL151
NCT02686294Phase 1
Repeated Dosing Clinical Trial of HL151
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4